Marimaca Appoints Giancarlo Bruno Lagomarsino as Non-Executive Director
November 01, 2023 07:47 ET
|
Marimaca Copper Corp.
VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Marimaca Copper Corp. (“Marimaca Copper” or the “Company”) (TSX: MARI) is pleased to announce the appointment of Giancarlo Bruno...
Marimaca Appoints Ausenco to Lead Marimaca Project Definitive Feasibility Study
October 30, 2023 07:00 ET
|
Marimaca Copper Corp.
VANCOUVER, British Columbia, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Marimaca Copper Corp. (“Marimaca Copper” or the “Company”) (TSX: MARI) is pleased to announce the appointment of Ausenco Chile Limitada...
Actimed Therapeutics Appoints Martin Walton as Chief Financial Officer
October 19, 2023 03:00 ET
|
Actimed Therapeutics
London, UK – 19th October 2023. Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and...
BWR Exploration Inc. Announces Jean-David Moore as an Advisor and Robert Suttie as Chief Financial Officer and the Grant of Stock Options
October 18, 2023 17:00 ET
|
BWR Exploration Inc.
TORONTO, Oct. 18, 2023 (GLOBE NEWSWIRE) -- BWR Exploration Inc. (TSX.V: BWR) (“BWR” or the “Company”) is pleased to announce the appointment of Mr. Jean-David Moore as an Advisor to the Company. ...
Banxa Announces Key Board Changes
October 16, 2023 07:59 ET
|
Banxa Holdings Inc.
This news release is intended for distribution only in Canada and is not intended for distribution to US newswire services, or for release, publication, or distribution in whole or in part, in or in...
Sound Bioventures appoints Fredrik Lehmann as its first Entrepreneur-in-Residence
October 13, 2023 03:00 ET
|
Sound Bioventures
Stockholm, Sweden and Cambridge, MA, USA – 13 October 2023 - Sound Bioventures, a venture capital fund investing in about-to-be clinical or clinical stage private companies in Europe and the USA...
Yves Bernaert est nommé Directeur Général d'Atos
October 04, 2023 02:30 ET
|
Atos International
Paris, France – 4 octobre, 2023 - Le Conseil d’administration d’Atos, réuni le 3 octobre 2023, suivant les recommandations du Comité des Nominations et de Gouvernance, a nommé Yves Bernaert Directeur...
Yves Bernaert is appointed Chief Executive Officer of Atos
October 04, 2023 02:30 ET
|
Atos International
Paris, France – October 4, 2023 - Atos's Board of Directors, at its meeting held on October 3rd, 2023, following the recommendations of the Nominations and Governance Committee, has appointed Yves...
Ajustement de la composition du Conseil d'administration
October 04, 2023 01:30 ET
|
Atos International
Paris, France – 4 octobre 2023 - Caroline Ruellan a décidé de démissionner du Conseil d'administration. Elle a été remplacée en tant que membre du Comité des Nominations et de Gouvernance par Carlo...
Adjustment in the composition of the Board of Directors
October 04, 2023 01:30 ET
|
Atos International
Paris, France – October 4, 2023 - Caroline Ruellan has decided to resign from the Board of Directors. She was replaced as member of the Nomination and Governance Committee by Carlo d'Asaro Biondo. ...